Avantor (AVTR) is in the spotlight after its CFO departure, recent CEO change and the ongoing Revival turnaround program, as the company reports flat year-on-year quarterly sales and keeps forward guidance intact.

Avantor's share price has weakened over time, with a 90 day share price return of 26.64% and a 1 year total shareholder return of 36.98%. This suggests sentiment has softened even as management pushes the Revival program and leadership changes.

If this kind of reset has you thinking about where else capital could work harder, it may be worth scanning for resilient businesses using our wide lens on 17 top founder-led companies

With the stock trading below some analyst price targets and the company resetting its fair value estimate to US$9.92 while still working through a turnaround, you have to ask: is there mispricing here, or is the market already factoring in whatever growth lies ahead?

Most Popular Narrative: 20% Undervalued

With Avantor's fair value narrative at $9.92 against a last close of $7.96, the gap between price and expectations is clear and invites a closer look.

The analysts have a consensus price target of $9.92 for Avantor based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $19.0, and the most bearish reporting a price target of just $7.0.

Curious what supports that valuation gap? Revenue edging higher, margins swinging from loss to profit, and a future earnings profile that assumes a very different company. The full narrative shows how those moving parts combine into one fair value story.

Result: Fair Value of $9.92 (UNDERVALUED)

However, the fair value story also relies on bioprocessing headwinds easing, as well as margin pressures from price cuts and high leverage not dragging profitability for longer than expected.

Next Steps

Seeing both risks and rewards in Avantor's story, it makes sense to move quickly and carefully review the data yourself with the 3 key rewards and 1 important warning sign

Looking for more investment ideas?

Do not stop your research with a single stock. Use powerful screeners to quickly spot other opportunities that could fit your goals before the crowd focuses on them.

• Contrast potential bargains across sectors by scanning our broad set of quality candidates using the 49 high quality undervalued stocks.
• Prioritize staying power by sorting companies with stronger finances through the solid balance sheet and fundamentals stocks screener (44 results).
• Hunt for underfollowed opportunities that still show robust fundamentals with the screener containing 25 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.